182 related articles for article (PubMed ID: 28246905)
1. Prevention of joint damage in hemophilic children with early prophylaxis.
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-346. PubMed ID: 28246905
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of joint damage in hemophilic children with early prophylaxis].
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
[TBL] [Abstract][Full Text] [Related]
3. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
[TBL] [Abstract][Full Text] [Related]
4. Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis.
Funk M; Schmidt H; Escuriola-Ettingshausen C; Pons S; Dzinaj T; Weimer C; Kornhuber B; Kreuz W
Ann Hematol; 1998 Oct; 77(4):171-4. PubMed ID: 9829849
[TBL] [Abstract][Full Text] [Related]
5. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis.
Olivieri M; Kurnik K; Pfluger T; Bidlingmaier C
Haemophilia; 2012 May; 18(3):369-74. PubMed ID: 22032268
[TBL] [Abstract][Full Text] [Related]
6. Haemophilia prophylaxis in young patients--a long-term follow-up.
Löfqvist T; Nilsson IM; Berntorp E; Pettersson H
J Intern Med; 1997 May; 241(5):395-400. PubMed ID: 9183307
[TBL] [Abstract][Full Text] [Related]
7. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
[TBL] [Abstract][Full Text] [Related]
8. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
Ahnström J; Berntorp E; Lindvall K; Björkman S
Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
Fischer K; Valentino L; Ljung R; Blanchette V
Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
[TBL] [Abstract][Full Text] [Related]
10. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
Khawaji M; Astermark J; Berntorp E
Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195
[TBL] [Abstract][Full Text] [Related]
11. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
[TBL] [Abstract][Full Text] [Related]
12. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia.
Nijdam A; Foppen W; van der Schouw YT; Mauser-Bunschoten EP; Schutgens RE; Fischer K
Haemophilia; 2016 Nov; 22(6):852-858. PubMed ID: 27396935
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the progression of haemophilic arthropathy in children.
Pergantou H; Platokouki H; Matsinos G; Papakonstantinou O; Papadopoulos A; Xafaki P; Petratos D; Aronis S
Haemophilia; 2010 Jan; 16(1):124-9. PubMed ID: 19744251
[TBL] [Abstract][Full Text] [Related]
15. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
16. Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands.
van Dijk K; Fischer K; van der Bom JG; Scheibel E; Ingerslev J; van den Berg HM
Br J Haematol; 2005 Jul; 130(1):107-12. PubMed ID: 15982352
[TBL] [Abstract][Full Text] [Related]
17. Early prophylaxis in children with severe haemophilia A: clinical and ultrasound imaging outcomes.
Altisent C; Martorell M; Crespo A; Casas L; Torrents C; Parra R
Haemophilia; 2016 Mar; 22(2):218-224. PubMed ID: 26315845
[TBL] [Abstract][Full Text] [Related]
18. Is on-demand treatment effective in patients with severe haemophilia?
Aznar JA; Marco A; Jiménez-Yuste V; Fernández-Fontecha E; Pérez R; Soto I; Parra R; Moreno M; Mingot ME; Moret A;
Haemophilia; 2012 Sep; 18(5):738-42. PubMed ID: 22537601
[TBL] [Abstract][Full Text] [Related]
19. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized.
Astermark J; Petrini P; Tengborn L; Schulman S; Ljung R; Berntorp E
Br J Haematol; 1999 Jun; 105(4):1109-13. PubMed ID: 10554828
[TBL] [Abstract][Full Text] [Related]
20. Value of routine ultrasound in detecting early joint changes in children with haemophilia using the 'Haemophilia Early Arthropathy Detection with UltraSound' protocol.
Foppen W; van der Schaaf IC; Fischer K
Haemophilia; 2016 Jan; 22(1):121-5. PubMed ID: 26228742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
